Biohaven Pharma (BHVN) Director Childs Buys $1M in Stock

March 17, 2021 5:18 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Biohaven Pharma (NYSE: BHVN) Director, John Childs, bought 13,157 shares on 03/17 at $76.

Shares appear to have been bought in the recent $200 million share offering.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insider Trades